Skip to content

Message from Aardvark Therapeutics

We’re pleased to share this message from Aardvark Therapeutics, who have reaffirmed their deep commitment to the Prader‑Willi syndrome (PWS) community.

FPWR UK remains in close and regular contact with Aardvark Therapeutics, who continue to show a strong commitment to the PWS community. We value these ongoing conversations as part of our shared goal to support research into safe and effective treatment options.

We’ll continue to keep our community informed as soon as we hear any more news.